Harnessing naturally occurring mutations for T-cell therapy: a potential new avenue to enhance treatment efficacy No … ← A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID Loss of tumor-derived SMAD4 enhances primary tumor growth but not metastasis following BMP4 signalling →